Hassan Al-Ali, Ph.D. - Publications

Affiliations: 
Miami Project University of Miami, Coral Gables, FL 
Area:
Neuroscience

21/153 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Mah KM, Wu W, Al-Ali H, Sun Y, Han Q, Ding Y, Muñoz M, Xu XM, Lemmon VP, Bixby JL. Corrigendum to "Compounds co-targeting kinases in axon regulatory pathways promote regeneration and behavioral recovery after spinal cord injury in mice" [Exp. Neurol. 355 (2022) 114117]. Experimental Neurology. 114669. PMID 38151457 DOI: 10.1016/j.expneurol.2023.114669  0.764
2022 Mah KM, Wu W, Al-Ali H, Sun Y, Han Q, Ding Y, Muñoz M, Xu XM, Lemmon VP, Bixby JL. Compounds co-targeting kinases in axon regulatory pathways promote regeneration and behavioral recovery after spinal cord injury in mice. Experimental Neurology. 114117. PMID 35588791 DOI: 10.1016/j.expneurol.2022.114117  0.786
2021 Ryan CB, Choi JS, Al-Ali H, Lee JK. Myelin and non-myelin debris contribute to foamy macrophage formation after spinal cord injury. Neurobiology of Disease. 105608. PMID 34979258 DOI: 10.1016/j.nbd.2021.105608  0.352
2021 Lowell JA, O'Neill N, Danzi MC, Al-Ali H, Bixby JL, Lemmon VP. Phenotypic Screening Following Transcriptomic Deconvolution to Identify Transcription Factors Mediating Axon Growth Induced by a Kinase Inhibitor. Slas Discovery : Advancing Life Sciences R & D. 24725552211026270. PMID 34218704 DOI: 10.1177/24725552211026270  0.772
2020 Patel AK, Broyer RM, Lee CD, Lu T, Louie MJ, La Torre A, Al-Ali H, Vu MT, Mitchell KL, Wahlin KJ, Berlinicke CA, Jaskula-Ranga V, Hu Y, Duan X, Vilar S, et al. Inhibition of GCK-IV kinases dissociates cell death and axon regeneration in CNS neurons. Proceedings of the National Academy of Sciences of the United States of America. PMID 33318207 DOI: 10.1073/pnas.2004683117  0.685
2019 Gautam P, Jaiswal A, Aittokallio T, Al-Ali H, Wennerberg K. Phenotypic Screening Combined with Machine Learning for Efficient Identification of Breast Cancer-Selective Therapeutic Targets. Cell Chemical Biology. PMID 31056464 DOI: 10.1016/J.Chembiol.2019.03.011  0.373
2018 Sartor GC, Malvezzi AM, Kumar A, Andrade NS, Wiedner HJ, Vilca SJ, Janczura KJ, Bagheri A, Al-Ali H, Powell SK, Brown PT, Volmar CH, Foster TC, Zeier Z, Wahlestedt C. Enhancement of BDNF expression and memory by HDAC inhibition requires BET bromodomain reader proteins. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30504275 DOI: 10.1523/Jneurosci.1604-18.2018  0.308
2018 Al-Ali H, Debevec G, Santos RG, Houghten RA, Davis JC, Nefzi A, Lemmon VP, Bixby JL, Giulianotti MA. Scaffold Ranking and Positional Scanning Identify Novel Neurite Outgrowth Promoters with Nanomolar Potency. Acs Medicinal Chemistry Letters. 9: 1057-1062. PMID 30344917 DOI: 10.1021/Acsmedchemlett.8B00425  0.719
2018 Strang BL, Asquith CRM, Moshrif HF, Ho CM, Zuercher WJ, Al-Ali H. Identification of lead anti-human cytomegalovirus compounds targeting MAP4K4 via machine learning analysis of kinase inhibitor screening data. Plos One. 13: e0201321. PMID 30048526 DOI: 10.1371/Journal.Pone.0201321  0.395
2018 Haggerty AE, Al-Ali H, Oudega M. Soluble laminin polymers enhance axon growth of primary neurons in vitro. Journal of Biomedical Materials Research. Part A. PMID 29637694 DOI: 10.1002/Jbm.A.36429  0.372
2018 Gautam P, Al-Ali H, Wennerberg K. Abstract A149: A chemical screening and machine learning approach to de-convolve kinase addictions in TNBC Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A149  0.353
2017 Al-Ali H, Gao H, Dalby-Hansen C, Peters VA, Shi Y, Brambilla R. High content analysis of phagocytic activity and cell morphology with PuntoMorph. Journal of Neuroscience Methods. PMID 28789994 DOI: 10.1016/J.Jneumeth.2017.08.004  0.332
2017 Drewry DH, Wells CI, Andrews DM, Angell R, Al-Ali H, Axtman AD, Capuzzi SJ, Elkins JM, Ettmayer P, Frederiksen M, Gileadi O, Gray N, Hooper A, Knapp S, Laufer S, et al. Progress towards a public chemogenomic set for protein kinases and a call for contributions. Plos One. 12: e0181585. PMID 28767711 DOI: 10.1371/Journal.Pone.0181585  0.324
2017 Al-Ali H, Ding Y, Slepak T, Wu W, Sun Y, Martinez Y, Xu XM, Lemmon VP, Bixby JL. The mTOR substrate S6 Kinase 1 (S6K1) is a negative regulator of axon regeneration and a potential drug target for Central Nervous System injury. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28626016 DOI: 10.1523/Jneurosci.0931-17.2017  0.752
2016 Al-Ali H, Lemmon VP, Bixby JL. Phenotypic Screening of Small-Molecule Inhibitors: Implications for Therapeutic Discovery and Drug Target Development in Traumatic Brain Injury. Methods in Molecular Biology (Clifton, N.J.). 1462: 677-88. PMID 27604745 DOI: 10.1007/978-1-4939-3816-2_37  0.71
2016 Callahan A, Abeyruwan SW, Al-Ali H, Sakurai K, Ferguson AR, Popovich PG, Shah NH, Visser U, Bixby JL, Lemmon VP. RegenBase: a knowledge base of spinal cord injury biology for translational research. Database : the Journal of Biological Databases and Curation. 2016. PMID 27055827 DOI: 10.1093/Database/Baw040  0.676
2016 Al-Ali H, Bixby JL, Lemmon VP. Exploiting kinase polypharmacology for nerve regeneration. Neural Regeneration Research. 11: 71-2. PMID 26981084 DOI: 10.4103/1673-5374.169614  0.68
2016 Al-Ali H, Beckerman S, Bixby JL, Lemmon VP. In vitro models of axon regeneration. Experimental Neurology. PMID 26826447 DOI: 10.1016/J.Expneurol.2016.01.020  0.728
2015 Beckerman SR, Jimenez JE, Shi Y, Al-Ali H, Bixby JL, Lemmon VP. Phenotypic Assays to Identify Agents That Induce Reactive Gliosis: A Counter-Screen to Prioritize Compounds for Preclinical Animal Studies. Assay and Drug Development Technologies. PMID 26230074 DOI: 10.1089/Adt.2015.654  0.737
2015 Al-Ali H, Lee DH, Danzi MC, Nassif H, Gautam P, Wennerberg K, Zuercher B, Drewry DH, Lee JK, Lemmon VP, Bixby JL. Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth. Acs Chemical Biology. PMID 26056718 DOI: 10.1021/Acschembio.5B00289  0.784
2013 Al-Ali H, Schürer SC, Lemmon VP, Bixby JL. Chemical interrogation of the neuronal kinome using a primary cell-based screening assay. Acs Chemical Biology. 8: 1027-36. PMID 23480631 DOI: 10.1021/Cb300584E  0.738
Low-probability matches (unlikely to be authored by this person)
2017 Yang H, Kurtenbach S, Guo Y, Lohse I, Durante MA, Li J, Li Z, Al-Ali H, Li L, Chen Z, Field MG, Zhang P, Chen S, Yamamoto S, Li Z, et al. Gain-of-function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies. Blood. PMID 29113963 DOI: 10.1182/Blood-2017-06-789669  0.299
2017 Swords RT, Azzam D, Al-Ali H, Lohse I, Volmar CH, Watts JM, Perez A, Rodriguez A, Vargas F, Elias R, Vega F, Zelent A, Brothers SP, Abbasi T, Trent J, et al. Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study. Leukemia Research. 64: 34-41. PMID 29175379 DOI: 10.1016/J.Leukres.2017.11.008  0.284
2007 Al-Ali H, Ragan TJ, Gao X, Harris TK. Reconstitution of modular PDK1 functions on trans-splicing of the regulatory PH and catalytic kinase domains. Bioconjugate Chemistry. 18: 1294-302. PMID 17500509 DOI: 10.1021/Bc070055R  0.281
2016 Al-Ali H. The evolution of drug discovery: from phenotypes to targets, and back Medchemcomm. 7: 788-798. DOI: 10.1039/C6Md00129G  0.272
2010 Al-Ali H, Rieger ME, Seldeen KL, Harris TK, Farooq A, Briegel KJ. Biophysical characterization reveals structural disorder in the developmental transcriptional regulator LBH. Biochemical and Biophysical Research Communications. 391: 1104-9. PMID 20005203 DOI: 10.1016/J.Bbrc.2009.12.032  0.249
2018 Lohse I, Al-Ali H, Volmar CH, D Alvarez Trotta A, Brothers SP, Capobianco AJ, Wahlestedt C. Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma. Plos One. 13: e0203173. PMID 30212533 DOI: 10.1371/Journal.Pone.0203173  0.245
2009 Nassif H, Al-Ali H, Khuri S, Keirouz W. Prediction of protein-glucose binding sites using support vector machines. Proteins. 77: 121-32. PMID 19415755 DOI: 10.1002/Prot.22424  0.239
2023 Ryan CB, Choi JS, Kang B, Herr S, Pereira C, Moraes CT, Al-Ali H, Lee JK. PI3K signaling promotes formation of lipid-laden foamy macrophages at the spinal cord injury site. Neurobiology of Disease. 106370. PMID 38049013 DOI: 10.1016/j.nbd.2023.106370  0.238
2019 Lohse I, Azzam DJ, Al-Ali H, Volmar CH, Brothers SP, Ince TA, Wahlestedt C. Ovarian Cancer Treatment Stratification Using Drug Sensitivity Testing. Anticancer Research. 39: 4023-4030. PMID 31366484 DOI: 10.21873/Anticanres.13558  0.233
2019 Mallela SK, Patel DM, Ducasa GM, Merscher S, Fornoni A, Al-Ali H. Detection and Quantification of Lipid Droplets in Differentiated Human Podocytes. Methods in Molecular Biology (Clifton, N.J.). 1996: 199-206. PMID 31127558 DOI: 10.1007/978-1-4939-9488-5_17  0.227
2023 Gurumani M, Mallela SK, Varona J, Merscher S, Fornoni A, Al-Ali H. A Robust Phenotypic Screening Assay Utilizing Human Podocytes to Identify Agents that Modulate Lipid Droplets. Methods in Molecular Biology (Clifton, N.J.). 2625: 163-174. PMID 36653642 DOI: 10.1007/978-1-0716-2966-6_15  0.22
2000 Al-Ali H, Fuleihan GE. Nutritional osteomalacia: substantial clinical improvement and gain in bone density posttherapy. Journal of Clinical Densitometry : the Official Journal of the International Society For Clinical Densitometry. 3: 97-101. PMID 10745306 DOI: 10.1385/Jcd:3:1:097  0.209
2007 Al-Ali H, Khachfe HM. The N-terminal domain of apolipoprotein B-100: structural characterization by homology modeling. Bmc Biochemistry. 8: 12. PMID 17659091 DOI: 10.1186/1471-2091-8-12  0.209
2010 Horn D, Zhou W, Trevisson E, Al-Ali H, Harris TK, Salviati L, Barrientos A. The conserved mitochondrial twin Cx9C protein Cmc2 Is a Cmc1 homologue essential for cytochrome c oxidase biogenesis. The Journal of Biological Chemistry. 285: 15088-99. PMID 20220131 DOI: 10.1074/Jbc.M110.104786  0.208
2016 Al-Ali H, Bixby JL, Lemmon VP. Exploiting kinase polypharmacology for nerve regeneration Neural Regeneration Research. 11: 71-72. DOI: 10.4103/1673-5374.169614  0.206
2022 Dennison JL, Al-Ali H, Volmar CH, Brothers S, Watts J, Wahlestedt C, Lohse I. Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients. Cancers. 14. PMID 36077629 DOI: 10.3390/cancers14174094  0.205
2002 Al-Ali H, Yabis AA, Issa E, Salem Z, Tawil A, Khoury N, Fuleihan Gel-H. Hypercalcemia in Langerhans' cell granulomatosis with elevated 1,25 dihydroxyvitamin D (calcitriol) level. Bone. 30: 331-4. PMID 11792606 DOI: 10.1016/S8756-3282(01)00651-2  0.202
2008 Horn D, Al-Ali H, Barrientos A. Cmc1p is a conserved mitochondrial twin CX9C protein involved in cytochrome c oxidase biogenesis. Molecular and Cellular Biology. 28: 4354-64. PMID 18443040 DOI: 10.1128/Mcb.01920-07  0.196
2022 Khalafi S, Zhu S, Khurana R, Lohse I, Giordano S, Corso S, Al-Ali H, Brothers SP, Wahlestedt C, Schürer S, El-Rifai W. A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer. Translational Oncology. 15: 101260. PMID 34735897 DOI: 10.1016/j.tranon.2021.101260  0.185
2021 Wells CI, Al-Ali H, Andrews DM, Asquith CRM, Axtman AD, Dikic I, Ebner D, Ettmayer P, Fischer C, Frederiksen M, Futrell RE, Gray NS, Hatch SB, Knapp S, Lücking U, et al. The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification. International Journal of Molecular Sciences. 22. PMID 33429995 DOI: 10.3390/ijms22020566  0.185
2012 Tschiedel S, Bach E, Jilo A, Wang SY, Lange T, Al-Ali HK, Vucinic V, Niederwieser D, Cross M. Bcr-Abl dependent post-transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemia. Leukemia & Lymphoma. 53: 1569-76. PMID 22251158 DOI: 10.3109/10428194.2012.656631  0.139
2003 Bumm T, Müller C, Al-Ali HK, Krohn K, Shepherd P, Schmidt E, Leiblein S, Franke C, Hennig E, Friedrich T, Krahl R, Niederwieser D, Deininger MW. Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority. Blood. 101: 1941-9. PMID 12411298 DOI: 10.1182/blood-2002-07-2053  0.119
2010 Nassif H, Al-Ali H, Khuri S, Keirouz W, Page D. An Inductive Logic Programming Approach to Validate Hexose Binding Biochemical Knowledge. Inductive Logic Programming. Ilp. 5989: 149-165. PMID 25309972 DOI: 10.1007/978-3-642-13840-9_14  0.115
2004 Al-Ali HK, Heinrich MC, Lange T, Krahl R, Mueller M, Müller C, Niederwieser D, Druker BJ, Deininger MW. High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib. The Hematology Journal : the Official Journal of the European Haematology Association / Eha. 5: 55-60. PMID 14745431 DOI: 10.1038/Sj.Thj.6200319  0.11
2012 Bach E, Krahl R, Lange T, Schüler F, Al-Ali H, Büchner T, Haferlach T, Dölken G, Niederwieser D, Cross M. Delayed processing of bone marrow samples reveals a prognostic pattern of NME mRNA expression in cytogenetically normal acute myeloid leukemia. Leukemia & Lymphoma. 53: 1561-8. PMID 22421058 DOI: 10.3109/10428194.2012.676176  0.108
2012 Harrison C, Kiladjian JJ, Al-Ali HK, Gisslinger H, Waltzman R, Stalbovskaya V, McQuitty M, Hunter DS, Levy R, Knoops L, Cervantes F, Vannucchi AM, Barbui T, Barosi G. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. The New England Journal of Medicine. 366: 787-98. PMID 22375970 DOI: 10.1056/NEJMoa1110556  0.108
2008 Pelz-Ackermann O, Cross M, Pfeifer H, Deininger M, Wang SY, Al-Ali HK, Niederwieser D, Lange T. Highly sensitive and quantitative detection of BCR-ABL kinase domain mutations by ligation PCR. Leukemia. 22: 2288-91. PMID 18615107 DOI: 10.1038/leu.2008.180  0.104
2006 Koch CA, Gimm O, Vortmeyer AO, Al-Ali HK, Lamesch P, Ott R, Kluge R, Bierbach U, Tannapfel A. Does the expression of c-kit (CD117) in neuroendocrine tumors represent a target for therapy? Annals of the New York Academy of Sciences. 1073: 517-26. PMID 17102120 DOI: 10.1196/Annals.1353.055  0.101
2020 Kim JJ, David JM, Wilbon SS, Santos JV, Patel DM, Ahmad A, Mitrofanova A, Liu X, Mallela SK, Ducasa GM, Ge M, Sloan AJ, Al-Ali H, Boulina M, Mendez AJ, et al. Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome. Ebiomedicine. 63: 103162. PMID 33340991 DOI: 10.1016/j.ebiom.2020.103162  0.098
2001 Al-Ali HMS, Durgham AK, Al-Khazalel N, Hisham-Rashdan. Creatine kinase, creatine kinase B - Subunit and ECG study in acute myocardial infarction Medical Forum Monthly. 12: 18-22.  0.098
2001 Al-Ali HMS, Durgham AK, Al- Khazalel N, Hisham-Rashdan A. Creatine kinase, creatine kinase B-subunit and ECG study in acute myocardial infarction Journal of the College of Physicians and Surgeons Pakistan. 11: 684-688.  0.098
2003 Lange T, Günther C, Köhler T, Krahl R, Musiol S, Leiblein S, Al-Ali HK, van Hoomissen I, Niederwieser D, Deininger MW. High levels of BAX, low levels of MRP-1, and high platelets are independent predictors of response to imatinib in myeloid blast crisis of CML. Blood. 101: 2152-5. PMID 12406906 DOI: 10.1182/blood-2002-05-1366  0.094
2023 Ge M, Molina J, Kim JJ, Mallela SK, Ahmad A, Varona Santos J, Al-Ali H, Mitrofanova A, Sharma K, Fontanesi F, Merscher S, Fornoni A. Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome. Elife. 12. PMID 37129368 DOI: 10.7554/eLife.83353  0.091
2012 Kiefer T, Hirt C, Späth C, Schüler F, Al-Ali HK, Wolf HH, Herbst R, Maschmeyer G, Helke K, Kessler C, Niederwieser D, Busemann C, Schroeder H, Vogelgesang S, Kirsch M, et al. Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onkologie OSHO-53 phase II study. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 23: 1809-12. PMID 22115927 DOI: 10.1093/annonc/mdr553  0.089
2004 Lange T, Deininger M, Brand R, Hegenbart U, Al-Ali H, Krahl R, Poenisch W, Uharek L, Leiblein S, Gentilini C, Petersdorf E, Storb RF, Niederwieser D. BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning. Leukemia. 18: 1468-75. PMID 15241437 DOI: 10.1038/sj.leu.2403425  0.086
2013 Cervantes F, Vannucchi AM, Kiladjian JJ, Al-Ali HK, Sirulnik A, Stalbovskaya V, McQuitty M, Hunter DS, Levy RS, Passamonti F, Barbui T, Barosi G, Harrison CN, Knoops L, Gisslinger H, et al. Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis. Blood. 122: 4047-53. PMID 24174625 DOI: 10.1182/blood-2013-02-485888  0.083
2007 Montemurro M, Kiefer T, Schüler F, Al-Ali HK, Wolf HH, Herbst R, Haas A, Helke K, Theilig A, Lotze C, Hirt C, Niederwieser D, Schwenke M, Krüger WH, Dölken G. Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche Studiengruppe Hamato-Onkologie OSHO-53 phase II study. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 18: 665-71. PMID 17185743 DOI: 10.1093/annonc/mdl458  0.081
2004 Lange T, Bumm T, Otto S, Al-Ali HK, Kovacs I, Krug D, Köhler T, Krahl R, Niederwieser D, Deininger MW. Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy. Haematologica. 89: 49-57. PMID 14754606  0.08
2002 Al-Ali HK, Leiblein S, Kovacs I, Hennig E, Niederwieser D, Deininger M. CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall. Blood. 100: 1092-3. PMID 12130477 DOI: 10.1182/blood-2002-03-0930  0.073
2014 Mesa RA, Kiladjian JJ, Verstovsek S, Al-Ali HK, Gotlib J, Gisslinger H, Levy R, Siulnik A, Gupta V, Khan M, DiPersio JF, McQuitty M, Catalano JV, Hunter DS, Knoops L, et al. Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies. Haematologica. 99: 292-8. PMID 23911705 DOI: 10.3324/haematol.2013.087650  0.072
2014 Al-Ali HK, Jaekel N, Niederwieser D. The role of hypomethylating agents in the treatment of elderly patients with AML. Journal of Geriatric Oncology. 5: 89-105. PMID 24484723 DOI: 10.1016/j.jgo.2013.08.004  0.072
2009 Al-Ali H, Cross M, Lange T, Freund M, Dölken G, Niederwieser D. Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia. Current Opinion in Oncology. 21: S17-22. PMID 19561407 DOI: 10.1097/01.cco.0000357470.91584.62  0.071
2014 Jaekel N, Behre G, Behning A, Wickenhauser C, Lange T, Niederwieser D, Al-Ali HK. Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib. Bone Marrow Transplantation. 49: 179-84. PMID 24292520 DOI: 10.1038/bmt.2013.173  0.071
2022 Mallela SK, Ge M, Molina J, Santos JV, Kim JJ, Mitrofanova A, Al-Ali H, Marples B, Merscher S, Fornoni A. Sphingomyelin phosphodiesterase acid like 3B (SMPDL3b) regulates Perilipin5 (PLIN5) expression and mediates lipid droplet formation. Genes & Diseases. PMID 35224168 DOI: 10.1016/j.gendis.2021.12.014  0.07
2015 Parris CN, Adam Zahir S, Al-Ali H, Bourton EC, Plowman C, Plowman PN. Enhanced γ-H2AX DNA damage foci detection using multimagnification and extended depth of field in imaging flow cytometry. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 87: 717-23. PMID 26087127 DOI: 10.1002/cyto.a.22697  0.07
2009 Bartsch K, Al-Ali H, Reinhardt A, Franke C, Hudecek M, Kamprad M, Tschiedel S, Cross M, Niederwieser D, Gentilini C. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used. Transplantation. 87: 217-21. PMID 19155975 DOI: 10.1097/TP.0b013e3181938998  0.068
2004 Niederwieser D, Gentilini C, Hegenbart U, Lange T, Moosmann P, Pönisch W, Al-Ali H, Raida M, Ljungman P, Tyndall A, Urbano-Ispizua A, Lazarus HM, Gratwohl A. Transmission of donor illness by stem cell transplantation: should screening be different in older donors? Bone Marrow Transplantation. 34: 657-65. PMID 15334048 DOI: 10.1038/sj.bmt.1704588  0.065
1999 al-Ali HY, Yasseen SA, Raof TY. Follow-up of pregnant women with active cytomegalovirus infection. Eastern Mediterranean Health Journal = La Revue De Santã© De La Mã©Diterranã©E Orientale = Al-Majallah Al-á¹£Iḥḥä«Yah Li-Sharq Al-Mutawassiá¹­. 5: 949-54. PMID 10983534  0.064
2005 Niederwieser D, Gentilini C, Hegenbart U, Lange T, Becker C, Wang SY, Bartsch K, Pönisch W, Raida M, Al-Ali H. Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias. Critical Reviews in Oncology/Hematology. 56: 275-81. PMID 16213741 DOI: 10.1016/j.critrevonc.2005.03.016  0.061
2022 Pressly JD, Gurumani MZ, Varona Santos JT, Fornoni A, Merscher S, Al-Ali H. Adaptive and maladaptive roles of lipid droplets in health and disease. American Journal of Physiology. Cell Physiology. PMID 35108119 DOI: 10.1152/ajpcell.00239.2021  0.06
2010 Edel E, Al-Ali HK, Seeger S, Kauschat D, Matthes G. Efficacy and Safety Profile of Solvent/Detergent Plasma in the Treatment of Acute Thrombotic Thrombocytopenic Purpura: A Single-Center Experience. Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie. 37: 13-19. PMID 20737012 DOI: 10.1159/000264996  0.06
2015 Pfrepper C, Klink A, Behre G, Schenk T, Franke GN, Jentzsch M, Schwind S, Al-Ali HK, Hochhaus A, Niederwieser D, Sayer HG. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation. Journal of Cancer Research and Clinical Oncology. PMID 26424692 DOI: 10.1007/s00432-015-2050-y  0.059
2005 Lange T, Bumm T, Mueller M, Otto S, Al-Ali HK, Grommisch L, Musiol S, Franke C, Krahl R, Niederwieser D, Deininger MW. Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation. Leukemia. 19: 1262-5. PMID 15858618 DOI: 10.1038/sj.leu.2403752  0.058
2005 Wetzig T, Sticherling M, Simon JC, Hegenbart U, Niederwieser D, Al-Ali HK. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin. Bone Marrow Transplantation. 35: 515-9. PMID 15665847 DOI: 10.1038/sj.bmt.1704804  0.056
2013 Cross M, Bach E, Tran T, Krahl R, Jaekel N, Niederwieser D, Junghanss C, Maschmeyer G, Al-Ali HK. Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemia. Oncotargets and Therapy. 6: 741-8. PMID 23836986 DOI: 10.2147/OTT.S45459  0.053
2013 Harrison CN, Mesa RA, Kiladjian JJ, Al-Ali HK, Gisslinger H, Knoops L, Squier M, Sirulnik A, Mendelson E, Zhou X, Copley-Merriman C, Hunter DS, Levy RS, Cervantes F, Passamonti F, et al. Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy. British Journal of Haematology. 162: 229-39. PMID 23672349 DOI: 10.1111/bjh.12375  0.052
2015 Koehler A, Hubert K, Lange T, Siebolts U, Wickenhauser C, Gopalakrishna P, Niederwieser D, Monecke A, Al-Ali HK. JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib. Annals of Hematology. 94: 1929-30. PMID 26202608 DOI: 10.1007/s00277-015-2454-4  0.052
2009 Avivi I, Montoto S, Canals C, Maertens J, Al-Ali H, Mufti GJ, Finke J, Schattenberg A, Fanin R, Cornelissen JJ, Vernant JP, Russell N, Beguin Y, Thomson K, Verdonck LF, et al. Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. British Journal of Haematology. 147: 719-28. PMID 19793383 DOI: 10.1111/j.1365-2141.2009.07905.x  0.052
2005 Kerbauy FR, Storb R, Hegenbart U, Gooley T, Shizuru J, Al-Ali HK, Radich JP, Maloney DG, Agura E, Bruno B, Epner EM, Chauncey TR, Blume KG, Niederwieser D, Sandmaier BM. Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML. Leukemia. 19: 990-7. PMID 15800667 DOI: 10.1038/Sj.Leu.2403730  0.051
2006 Hegenbart U, Niederwieser D, Sandmaier BM, Maris MB, Shizuru JA, Greinix H, Cordonnier C, Rio B, Gratwohl A, Lange T, Al-Ali H, Storer B, Maloney D, McSweeney P, Chauncey T, et al. Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 444-53. PMID 16344316 DOI: 10.1200/Jco.2005.03.1765  0.05
2011 Lange T, Hubmann M, Burkhardt R, Franke GN, Cross M, Scholz M, Leiblein S, Al-Ali HK, Edelmann J, Thiery J, Niederwieser D. Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning. Leukemia. 25: 498-505. PMID 21135860 DOI: 10.1038/leu.2010.283  0.05
2015 Jaekel N, Lieder K, Albrecht S, Leismann O, Hubert K, Bug G, Kröger N, Platzbecker U, Stadler M, de Haas K, Altamura S, Muckenthaler MU, Niederwieser D, Al-Ali HK. Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. PMID 26367238 DOI: 10.1038/bmt.2015.204  0.048
2015 Kahl C, Krahl R, Becker C, Al-Ali HK, Sayer HG, Schulze A, Herold M, Hänel M, Scholl S, Hochhaus A, Uharek L, Maschmeyer G, Haehling D, Junghanß C, Peter N, et al. Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO). Journal of Cancer Research and Clinical Oncology. PMID 26407768 DOI: 10.1007/s00432-015-2045-8  0.047
2008 Hudecek M, Bartsch K, Jäkel N, Heyn S, Pfannes R, Al-Ali HK, Cross M, Pönisch W, Gerecke U, Edelmann J, Ittel T, Niederwieser D. Spontaneous remission of acute myeloid leukemia relapse after hematopoietic cell transplantation in a high-risk patient with 11q23/MLL abnormality. Acta Haematologica. 119: 111-4. PMID 18367831 DOI: 10.1159/000121827  0.047
2011 Eisfeld AK, Westerman M, Krahl R, Leiblein S, Liebert UG, Hehme M, Teupser D, Niederwieser D, Al-Ali HK. Highly Elevated Serum Hepcidin in Patients with Acute Myeloid Leukemia prior to and after Allogeneic Hematopoietic Cell Transplantation: Does This Protect from Excessive Parenchymal Iron Loading? Advances in Hematology. 2011: 491058. PMID 21687645 DOI: 10.1155/2011/491058  0.047
2015 Niederwieser C, Starke S, Fischer L, Krahl R, Beck J, Gruhn B, Ebell W, Körholz D, Wößmann W, Bader P, Lang P, Al-Ali HK, Cross M, Eisfeld AK, Heyn S, et al. Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations. Annals of Hematology. PMID 26696465 DOI: 10.1007/s00277-015-2569-7  0.047
2010 Schlaak M, Schwind S, Wetzig T, Maschke J, Treudler R, Basara N, Lange T, Simon JC, Niederwieser D, Al-Ali HK. UVA (UVA-1) therapy for the treatment of acute GVHD of the skin. Bone Marrow Transplantation. 45: 1741-8. PMID 20921941 DOI: 10.1038/bmt.2010.230  0.046
2006 Then Bergh F, Niklas A, Strauss A, von Ahsen N, Niederwieser D, Schwarz J, Wagner A, Al-Ali HK. Rapid progression of Myelodysplastic syndrome to acute myeloid leukemia on sequential azathioprine, IFN-beta and copolymer-1 in a patient with multiple sclerosis. Acta Haematologica. 116: 207-10. PMID 17016041 DOI: 10.1159/000094683  0.046
2006 Niederwieser D, Lange T, Cross M, Basara N, Al-Ali H. Reduced intensity conditioning (RIC) haematopoietic cell transplants in elderly patients with AML. Best Practice & Research. Clinical Haematology. 19: 825-38. PMID 16997186 DOI: 10.1016/j.beha.2006.06.007  0.044
2007 Schaich M, Schlenk RF, Al-Ali HK, Döhner H, Ganser A, Heil G, Illmer T, Krahl R, Krauter J, Sauerland C, Büchner T, Ehninger G. Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup. Haematologica. 92: 763-70. PMID 17550848 DOI: 10.3324/haematol.11100  0.042
1992 Al-Ali HH, Selim MS. Simultaneous development of velocity and temperature profiles in the entrance region of a parallel plate channel: Laminar flow with uniform wall heat flux Chemical Engineering Communications. 112: 1-19. DOI: 10.1080/00986449208935988  0.042
2007 Al-Ali HK, Wittekind C, Niederwieser D. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab]. Deutsche Medizinische Wochenschrift (1946). 132: 1688-91. PMID 17713864 DOI: 10.1055/s-2007-984950  0.041
2015 Dombret H, Seymour JF, Butrym A, Wierzbowska A, Selleslag D, Jang JH, Kumar R, Cavenagh J, Schuh AC, Candoni A, Récher C, Sandhu I, Bernal Del Castillo T, Al-Ali HK, Martinelli G, et al. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts. Blood. 126: 291-9. PMID 25987659 DOI: 10.1182/blood-2015-01-621664  0.04
2005 Sorror ML, Maris MB, Sandmaier BM, Storer BE, Stuart MJ, Hegenbart U, Agura E, Chauncey TR, Leis J, Pulsipher M, McSweeney P, Radich JP, Bredeson C, Bruno B, Langston A, ... ... Al-Ali H, et al. Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3819-29. PMID 15809448 DOI: 10.1200/JCO.2005.04.569  0.04
2014 Serrano PE, Serra S, Al-Ali H, Gallinger S, Greig PD, McGilvray ID, Moulton CA, Wei AC, Cleary SP. Risk factors associated with recurrence in patients with solid pseudopapillary tumors of the pancreas. Jop : Journal of the Pancreas. 15: 561-8. PMID 25435571 DOI: 10.6092/1590-8577/2423  0.039
2014 Platzbecker U, Al-Ali HK, Gattermann N, Haase D, Janzen V, Krauter J, Götze K, Schlenk R, Nolte F, Letsch A, Ottmann OG, Kündgen A, Lübbert M, Germing U, Wermke M, et al. Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients. Leukemia. 28: 696-8. PMID 24186004 DOI: 10.1038/leu.2013.325  0.036
2013 Pönisch W, Heyn S, Beck J, Wagner I, Mohren M, Hoffmann FA, Lange T, Schmalfeld M, Zehrfeld T, Schwarzer A, Winkelmann C, Edelmann T, Röhrborn R, Hebenstreit K, Al-Ali HK, et al. Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077. British Journal of Haematology. 162: 202-9. PMID 23692564 DOI: 10.1111/bjh.12361  0.036
2012 Al-Ali HK, Jaekel N, Junghanss C, Maschmeyer G, Krahl R, Cross M, Hoppe G, Niederwieser D. Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II study. Leukemia & Lymphoma. 53: 110-7. PMID 21767242 DOI: 10.3109/10428194.2011.606382  0.036
2015 Wang SY, Ebert T, Jaekel N, Schubert S, Niederwieser D, Al-Ali HK. Miliary tuberculosis after initiation of ibrutinib in chronic lymphocytic leukemia. Annals of Hematology. 94: 1419-20. PMID 25903044 DOI: 10.1007/s00277-015-2385-0  0.033
2011 de Hosson LD, van de Warrenburg BP, Preijers FW, Blijlevens NM, van der Reijden BA, Kremer HP, Lefeber DJ, Allebes WA, Al-Ali H, Niederwieser DW, Schaap NP, Schattenberg AV. Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature. Bone Marrow Transplantation. 46: 1071-6. PMID 21042305 DOI: 10.1038/bmt.2010.252  0.033
2001 Al-Ali HA, Salamy SP, Haq SA. The Challenges of Detecting Gas Entries in Horizontal Well by Using Integrated Production Logging Tool, Case Study Proceedings of the Middle East Oil Show. 46-55.  0.033
2009 Basara N, Schulze A, Wedding U, Mohren M, Gerhardt A, Junghanss C, Peter N, Dölken G, Becker C, Heyn S, Kliem C, Lange T, Krahl R, Pönisch W, Fricke HJ, ... ... Al-Ali H, et al. Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission. Leukemia. 23: 635-40. PMID 19151786 DOI: 10.1038/leu.2008.352  0.033
2007 Al-Ali HK, Wittekind C, Niederwieser D. Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab | Komplette remission eines rezidivierenden Hodgkin-lymphoms vom mischzelligen typ nach rituximab-therapie Tumor Diagnostik Und Therapie. 28: 242-245. DOI: 10.1055/s-2007-963608  0.032
2008 Schlaak M, Treudler R, Colsman A, Al-Ali H, Simon JC. Oral graft-versus-host disease: successful therapy with extracorporeal photopheresis and topical tacrolimus. Journal of the European Academy of Dermatology and Venereology : Jeadv. 22: 112-3. PMID 18181987 DOI: 10.1111/j.1468-3083.2007.02272.x  0.032
2016 Al-Ali HK, Stalbovskaya V, Gopalakrishna P, Perez-Ronco J, Foltz L. Impact of ruxolitinib treatment on the hemoglobin dynamics and the negative prognosis of anemia in patients with myelofibrosis Leukemia and Lymphoma. 1-4. DOI: 10.3109/10428194.2016.1146950  0.032
2008 Al-Ali H, Al-Qahtani K, Elkamel A. A mathematical programming model for achieving total emission control in the petroleum refining industry International Journal of Oil, Gas and Coal Technology. 1: 444-463. DOI: 10.1504/IJOGCT.2008.020372  0.03
2014 Hassanein M, Belhadj M, Abdallah K, Bhattacharya AD, Singh AK, Tayeb K, Al-Arouj M, Elghweiry A, Iraqi H, Nazeer M, Jamoussi H, Mnif M, Al-Madani A, Al-Ali H, Ligthelm R. Management of Type 2 diabetes in Ramadan: Low-ratio premix insulin working group practical advice. Indian Journal of Endocrinology and Metabolism. 18: 794-9. PMID 25364673 DOI: 10.4103/2230-8210.140242  0.029
2006 Haberl A, Houghton B, Al-Ali HH. Turnkey solutions for the modern-day primary aluminium Casthouse: The Alba Line 5 experience Tms Light Metals. 2006: 877-880.  0.026
2003 Al-Ali HM, El Taji H, Faour I. Osteitis fibrosa cystica: Rapid gain in bone mineral density after parathyroidectomy Emirates Medical Journal. 21: 257-259.  0.024
2019 Benameur T, Al-Bohassan H, Al-Aithan A, Al-Beladi A, Al-Ali H, Al-Omran H, Saidi N. Knowledge, attitude, behaviour of the future healthcare professionals towards the self-medication practice with antibiotics. Journal of Infection in Developing Countries. 13: 56-66. PMID 32032024 DOI: 10.3855/jidc.10574  0.024
1980 Al-Ali HM, Burdekin R. An analysis of the economic impact of north sea oil activity on the scottish economy in 1973 Managerial and Decision Economics. 1: 67-72. DOI: 10.1002/mde.4090010205  0.024
2015 Dombret H, Seymour JF, Butrym A, Wierzbowska A, Selleslag D, Jang JH, Kumar R, Cavenagh J, Schuh AC, Candoni A, Récher C, Sandhu I, Del Castillo TB, Al-Ali HK, Martinelli G, et al. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts Blood. 126: 291-299. DOI: 10.1182/blood-2015-01-621664  0.024
1993 Al-Ali HH, Selim MS. Momentum and heat transfer in the entrance region of a parallel plate channel: developing laminar flow with constant wall temperature Applied Scientific Research. 51: 663-675. DOI: 10.1007/BF00849271  0.024
2014 Aloul F, Zualkernan I, Abu-Salma R, Al-Ali H, Al-Merri M. iBump: Smartphone application to detect car accidents Proceedings - International Conference On Industrial Automation, Information and Communications Technology, Iaict 2014. 52-56. DOI: 10.1109/IAICT.2014.6922107  0.023
2015 McMullin MF, Harrison CN, Niederwieser D, Demuynck H, Jäkel N, Gopalakrishna P, McQuitty M, Stalbovskaya V, Recher C, Theunissen K, Gisslinger H, Kiladjian JJ, Al-Ali HK. The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis. Experimental Hematology & Oncology. 4: 26. PMID 26380150 DOI: 10.1186/s40164-015-0021-2  0.023
2015 Gerber LM, Bener A, Al-Ali HM, Hammoudeh M, Liu LQ, Verjee M. Bone mineral density in midlife women: the Study of Women's Health in Qatar. Climacteric : the Journal of the International Menopause Society. 18: 316-22. PMID 25032729 DOI: 10.3109/13697137.2014.944495  0.023
2012 Giagounidis A, Al-Ali H, Mohr A, Haase D, Hofmann WK, Kreuzer KA, Gattermann N. Iron chelaton therapy with Deferasirox: Optimizing dosage and therapy initiation | Eisenchelat-Therapie mit Deferasirox: Therapiebeginn und Dosisoptimierung Tumor Diagnostik Und Therapie. 33: 29-33. DOI: 10.1055/s-0031-1281866  0.022
2013 Nanji S, Cleary S, Ryan P, Guindi M, Selvarajah S, Al-Ali H, Grieg P, McGilvary I, Taylor B, Wei A, Moulton CA, Gallinger S. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival. Annals of Surgical Oncology. 20: 295-304. PMID 23054102 DOI: 10.1245/s10434-012-2424-1  0.022
2015 Rockstroh A, Al-Ali HK, Lange T, Pönisch W, Krahl R, Cross M, Behre G, Niederwieser D, Pfrepper C. Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation. Journal of Cancer Research and Clinical Oncology. PMID 26129640 DOI: 10.1007/s00432-015-2003-5  0.021
1982 Said AS, Al-Nafea M, Al-Ali H, Hamad E. CONCENTRATION PROFILES AND BREAKTHROUGH CURVES IN NON-LINEAR CHROMATOGRAPHY Hrc & Cc. Journal of High Resolution Chromatography & Chromatography Communications. 5: 674-680.  0.021
1997 Chebbi R, Al-Ali HH, Selim MS. Simultaneously developing laminar flow and heat transfer in the entrance region of a circular tube with constant wall temperature Chemical Engineering Communications. 160: 59-70.  0.02
2007 Al-Ali HK, Brand R, van Biezen A, Finke J, Boogaerts M, Fauser AA, Egeler M, Cahn JY, Arnold R, Biersack H, Niederwieser D, de Witte T. A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Leukemia. 21: 1945-51. PMID 17611571 DOI: 10.1038/sj.leu.2404774  0.02
2013 Serrano PE, Al-Ali H, Gallinger S, McGilvray ID, Moulton C, Wei AC, Serra S, Cleary S. Mo1742 Clinico-Pathological Features of Solid Pseudopapillary Neoplasms of the Pancreas Gastroenterology. 144: S-1105. DOI: 10.1016/S0016-5085(13)64117-7  0.02
2000 Fathi AM, Al-Ali HM, Athamneh E. Cross infection in postoperative wounds through ultrasound probes Journal of the College of Physicians and Surgeons Pakistan. 10: 416-417.  0.018
1997 Demirel Y, Al-Ali HH, Abu-Al-Saud BA. Entropy generation of convection heat transfer in an asymmetrically heated packed duct International Communications in Heat and Mass Transfer. 24: 381-390. DOI: 10.1016/S0735-1933(97)00023-7  0.018
2012 Eisfeld AK, Krahl R, Jaekel N, Niederwieser D, Al-Ali HK. Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation. American Journal of Blood Research. 2: 243-53. PMID 23226624  0.018
2001 Amabeoku MO, Funk JJ, Al-Dossary SM, Al-Ali HA. Calibration of Permeability Derived from NMR Logs in Carbonate Reservoirs Proceedings of the Middle East Oil Show. 171-181.  0.017
2005 AlKhalifah K, Brindhaban A, Al-Ali H, Alhuraibi A. The stability of dry and wet laser imaging systems. Radiologic Technology. 76: 192-6. PMID 15732890  0.017
2014 Serrano PE, Grant RC, Berk TC, Kim D, Al-Ali H, Cohen Z, Pollett A, Riddell R, Silverberg MS, Kortan P, May GR, Gallinger S. Progression and Management of Duodenal Neoplasia in Familial Adenomatous Polyposis: A Cohort Study. Annals of Surgery. PMID 24950262 DOI: 10.1097/SLA.0000000000000734  0.016
1998 Makkawi Y, Demirel Y, Al-Ali HH. Numerical analysis of convection heat transfer in a rectangular packed duct with asymmetric heating Energy Conversion and Management. 39: 455-463. DOI: 10.1016/S0196-8904(97)00026-5  0.014
2003 Bredt M, Schönfeld G, Kleeberger W, König E, Kröning H, Kettner E, Al-Ali HK, Niederwieser D, Kreipe H. Late-onset Epstein-Barr virus (EBV)-negative extranodal B-precursor lymphoblastic lymphoma of donor origin after hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplantation. 31: 1071-2. PMID 12774065 DOI: 10.1038/sj.bmt.1704035  0.014
2011 Al-Ali HK, Bourgeois M, Krahl R, Edel E, Leiblein S, Poenisch W, Basara N, Lange T, Niederwieser D. The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 46: 1296-302. PMID 21132022 DOI: 10.1038/bmt.2010.310  0.014
2001 Ballay G, Al-Ali H, Amos S, Dennis B. In the driver's seat with LWD azimuthal density images Jpt, Journal of Petroleum Technology. 53: 39.  0.014
2000 Aitani AM, Ali MF, Al-Ali HH. Review of non-conventional methods for the desulfurization of residual fuel oil Petroleum Science and Technology. 18: 537-553.  0.014
1997 Demirel Y, Al-Ali HH. Thermodynamic analysis of convective heat transfer in a packed duct with asymmetrical wall temperatures International Journal of Heat and Mass Transfer. 40: 1145-1153. DOI: 10.1016/0017-9310(96)00102-0  0.014
1983 Al-Ali HM. TOWARDS A COMPREHENSIVE AND INTEGRATED PLAN FOR ENERGY UTILIZATION AND POLICY IN THE ARAB GULF COUNTRIES . 2-8.  0.014
2004 Kersey DG, Al-Ali HA, Eyvazzadeh RY, Phillips C, Tjan TL. Log reprocessing: Petrophysical lessons from the giant oil and gas fields of Saudi Arabia Proceedings - Spe Annual Technical Conference and Exhibition. 169-179.  0.013
2000 Al-Ali HMS, Rashdan H. Lipid and lipoprotein changes in Jordanian of chronic heart diseases Journal of the College of Physicians and Surgeons Pakistan. 10: 371-374.  0.013
1999 Demirel Y, Abu-Al-Saud BA, Al-Ali HH, Makkawi Y. Packing size and shape effects on forced convection in large rectangular packed ducts with asymmetric heating International Journal of Heat and Mass Transfer. 42: 3267-3277. DOI: 10.1016/S0017-9310(98)00370-6  0.012
1999 Demirel Y, Al-Ali HH, Abu-Al-Saud BA. Enhancement of convection heat-transfer in a rectangular duct Applied Energy. 64: 441-451. DOI: 10.1016/S0306-2619(99)00110-5  0.012
2015 Gerber LM, Giambrone AE, Al-Ali HM, Verjee MA. Validity of self-reported vitamin D deficiency among midlife Arab women living in Qatar. American Journal of Human Biology : the Official Journal of the Human Biology Council. PMID 26345363 DOI: 10.1002/ajhb.22766  0.01
2013 Serrano PE, Kim PT, Naman G, Al-Ali H, Cleary S, Greig PD, McGilvray ID, Moulton C, Gallinger S, Wei AC. Mo1738 Risk-Benefit Assessment of the Use of Intraperitoneal Drainage After Pancreaticoduodenectomy Gastroenterology. 144: S-1103. DOI: 10.1016/S0016-5085(13)64113-X  0.01
2011 Al-Ghamdi T, Al-Ali H, Zahdan G, Al-Nahwi I, Tjwan T, Readean M. Evolution of petrophysical data management in Saudi Aramco Spe Middle East Oil and Gas Show and Conference, Meos, Proceedings. 2: 1416-1421.  0.01
2006 Kareeri AA, Zughbi HD, Al-Ali HH. Simulation of flow distribution in radial flow reactors Industrial and Engineering Chemistry Research. 45: 2862-2874. DOI: 10.1021/ie050027x  0.01
2005 Al-Ali HA, Worthington PF. Applications of petrophysical scale reconciliation to Saudi Arabian reservoirs 2005 International Petroleum Technology Conference Proceedings. 1291-1296.  0.01
2002 Al-Ali HMS, Abu-Lubad AA. Limitation of cholestrol measurement as the only indicator of CHD risk Journal of the Bahrain Medical Society. 14: 123-128.  0.01
2000 Demirel Y, Sharma RN, Al-Ali HH. On the effective heat transfer parameters in a packed bed International Journal of Heat and Mass Transfer. 43: 327-332. DOI: 10.1016/S0017-9310(99)00126-X  0.01
1996 Demirel Y, Al-Ali HH, Abu-Al-Saud BA. Volumetric entropy generation of convective heat transfer in an asymmetrically heated packed duct International Symposium On Heat Transfer. 520-525.  0.01
1996 Bell IA, Al-Daini AJ, Al-Ali H, Abdel-Gayed RG, Duckers L. The design of an evaporator/absorber and thermodynamic analysis of a vapor absorption chiller driven by solar energy Renewable Energy. 9: 657-660.  0.01
1992 Al-Ali HH, Sami Selim M. Analysis of laminar flow forced convection heat transfer with uniform heating in the entrance region of a circular tube Canadian Journal of Chemical Engineering. 70: 1101-1107.  0.01
1982 Said AS, Al-Ali H, Hamad E. MATHEMATICS FOR CHROMATOGRAPHY - 1. CONCENTRATION DISTRIBUTIONS AND THEIR MOMENTS Hrc & Cc. Journal of High Resolution Chromatography & Chromatography Communications. 5: 306-310.  0.01
1979 Al-Ali HM. Input-output analysis of energy requirements. An application to the Scottish economy in 1973 Energy Economics. 1: 211-218. DOI: 10.1016/0140-9883(79)90003-3  0.01
Hide low-probability matches.